Search

Medpace Holdings Inc

Lezárt

SzektorEgészségügy

618.92 0.4

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

611.98

Maximum

635.96

Fő mutatók

By Trading Economics

Bevétel

-2.5M

121M

Értékesítés

727K

707M

P/E

Szektor átlag

36.377

48.735

Egy részvényre jutó nyereség

4.25

Profit margin

17.158

Munkavállalók

6,500

EBITDA

-6.9M

148M

Ajánlások

By TipRanks

Ajánlások

Semleges

12 hónapos előrejelzés

-1.22% downside

Osztalékok

By Acuity

Következő eredményjelentés

2026. okt. 21.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

2.2B

17B

Előző nyitás

618.52

Előző zárás

618.92

Medpace Holdings Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. okt. 16. 20:07 UTC

Medpace Holdings Inc shares are declining, finishing significantly lower since Thursday's close, despite a slight recovery earlier in the session.

2026. okt. 15. 20:07 UTC

Social Media
Correlated Moves

Medpace Holdings Inc shares advanced during Thursday's session, supported by a maintained Buy rating on Thermo Fisher Scientific Inc and strong user commentary on performance.

2026. okt. 14. 20:07 UTC

Medpace Holdings Inc shares are advancing, following an early surge that marked its highest cumulative return, despite some retracement during Wednesday's trading session.

2026. okt. 12. 19:56 UTC

Medpace Holdings Inc is trading higher, having gained traction since Friday and currently positioned above its 20-day moving average.

2026. okt. 9. 20:06 UTC

Medpace Holdings Inc is advancing, benefiting from broader market gains since Thursday, despite pulling back slightly from an earlier session peak.

2026. okt. 8. 21:40 UTC

Medpace Holdings Inc is trading lower in after-market hours, continuing a decline since Thursday's close and indicating ongoing weakness below its 20-day moving average.

2026. okt. 6. 20:00 UTC

Correlated Moves
News

Medpace Holdings Inc shares fell amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing involving the company and its officers.

2026. okt. 5. 20:01 UTC

Correlated Moves

Charles River Laboratories is sharply higher after a positive earnings report, while Medpace Holdings is also advancing, despite earlier pulling back from a session high.

2026. okt. 1. 20:02 UTC

Correlated Moves

Medpace Holdings Inc shares fell amid a broader market decline, reversing the recent trend of higher daily closes since Wednesday's close.

2026. szept. 30. 19:35 UTC

News

UBS upgraded Medpace Holdings Inc to Neutral with a price target of $673, as shares trade higher amid strong historical performance despite recent insider selling.

2026. szept. 25. 20:07 UTC

Correlated Moves

Medpace Holdings Inc shares fell, reflecting a decline from Thursday's close, amid sympathy with Thermo Fisher Scientific Inc, which is also down.

2026. szept. 24. 20:07 UTC

Correlated Moves
News

Medpace shares are modestly higher as President and CEO August J. Troendle sold 70.9k shares for about $44.43 million, following strong revenue growth.

2026. szept. 23. 20:01 UTC

Correlated Moves

Medpace Holdings Inc shares fell sharply on Wednesday, aligning with a decline in Charles River Laboratories, despite remaining above its 20-day moving average.

2026. szept. 22. 23:01 UTC

Medpace Holdings Inc is rising in after-market trading, continuing a trend above its 20-day moving average and closing higher for three consecutive sessions.

2026. szept. 15. 20:01 UTC

Medpace Holdings Inc. is trading higher today despite negative broader market sentiment following a significant drop in the NY Empire State Manufacturing Index.

2026. szept. 11. 20:08 UTC

Medpace Holdings Inc. is advancing during Friday's session, having reached a session high earlier, though it has since pulled back from that peak.

2026. szept. 3. 20:07 UTC

News

Medpace Holdings shares are declining amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing involving the company and its officers.

2026. szept. 2. 20:08 UTC

Medpace Holdings Inc. is rising amid broader gains in the Life Sciences Tools & Services sector, despite no specific company news driving the movement.

2026. szept. 1. 20:08 UTC

Correlated Moves
News

Medpace Holdings Inc shares are lower amid insider selling and an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing.

2026. aug. 31. 20:07 UTC

Correlated Moves

Medpace Holdings shares are lower today, reflecting broader sector dynamics and rising interest rate expectations following the Jackson Hole Economic Symposium.

2026. aug. 26. 20:08 UTC

Medpace Holdings Inc. shares are higher today, continuing an upward trend since Tuesday's close. The stock remains above its 20-day moving average.

2026. aug. 25. 20:07 UTC

News

Shares of Medpace Holdings Inc are trading lower amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing by company officers.

2026. aug. 20. 19:41 UTC

Social Media

Medpace Holdings Inc. is rising amid strong gains in the Life Sciences Tools & Services sector and positive sentiment surrounding biotech investments.

2026. aug. 19. 20:02 UTC

Medpace Holdings Inc. shares are higher, driven by a significant advance in the Life Sciences Tools & Services sub-sector amid a strong market session.

2026. aug. 17. 20:02 UTC

News

Medpace Holdings Inc. shares are higher following a Barron's report suggesting significant upside potential and robust Q2 results exceeding analyst expectations.

2026. aug. 14. 19:36 UTC

Medpace Holdings Inc shares are lower amid broader market sentiment following a Commerce Department report showing a decline in retail sales for July.

2026. aug. 13. 19:56 UTC

News

Medpace Holdings shares are lower as CEO August J. Troendle sold 23,144 shares valued at $13.98 million, raising investor concerns about future performance.

2026. aug. 7. 19:16 UTC

Medpace Holdings Inc. shares are lower today, reflecting a slight pullback amid broader market factors, including economic signals and geopolitical tensions.

2026. aug. 3. 19:26 UTC

Medpace Holdings Inc shares are higher, tracking broader market gains as major technology stocks boost investor confidence amid declining energy prices.

2026. júl. 30. 19:22 UTC

Medpace Holdings Inc is trading lower amid significant declines in the Life Sciences Tools & Services sub-sector, with unusual volatility noted during Thursday's session.

Társak összehasonlítása

Árváltozás

Medpace Holdings Inc Előrejelzés

Célár

By TipRanks

-1.22% elmozdulás lefelé

12 hónapos előrejelzés

Átlag 612.1 USD  -1.22%

Magas 700 USD

Alacsony 492 USD

12 Wall Street elemző 12 hónapos célárain alapulva a(z)Medpace Holdings Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Semleges

12 ratings

2

Vétel

10

Tartás

0

Eladás

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
help-icon Live chat